Statin use among patients with chronic liver disease was associated with a reduced risk of liver cancer and hepatic decompensation. Users had a 33% lower risk for liver cancer and a 22% lower risk for ...

A newly identified population of dysfunctional immune cells may play a central role in both aging and chronic disease.

Please provide your email address to receive an email when new articles are posted on . In 2023, nearly a third of hospitalized patients with chronic liver disease had acute kidney injury or ...

Advanced liver disease (ALD) occurs when significant scarring causes the liver to lose function. Patients with ALD often have ...

Scientists at UCLA have uncovered a medical breakthrough that could be a potential miracle for millions of Los Angeles ...

News and commentary from the world of gastroenterology and hepatology ...

Advanced liver disease (ALD) occurs when significant scarring causes the liver to lose function. Patients with ALD often have ...

Fatty liver disease alters gut and immune responses, enabling harmful bacteria to worsen infections, while microbiome ...

Wegovy can now be used in adults with metabolic-associated steatohepatitis (MASH) who have excessive scar tissue in their liver. The FDA has expanded Wegovy use to include adults with ...

Hepatic encephalopathy (HE) is a condition that can affect the brain in people who have chronic liver disease. It happens when a damaged liver cannot effectively filter ammonia and other toxins out of ...

Every day, the liver packages fat and releases it into the bloodstream to fuel the body, supplying energy to the heart, ...

What Is Metabolic Dysfunction-Associated Steatohepatitis? Metabolic dysfunction-associated steatohepatitis, or MASH, is a form of liver disease. MASH occurs when fat accumulates in liver cells. Plenty ...